Adoptive Immunotherapy of Ovarian Carcinoma To the Editor

By de Gramont A.   Gangji D.   Louvet C.   Garcia M.L.   Tardy D.   Romet-Lemonne J.L.  

Gynecologic Oncology, Vol. 86, Iss. 1, 2002-07 ,pp. : 102-103

Academic Press

Access to resources Recommend Favorite

Irradiated KHYG-1 retains cytotoxicity: Potential for adoptive immunotherapy with a natural killer cell line

By Suck G.   Branch D.   Keating A.  

International Journal of Radiation Biology, Vol. 82, Iss. 5, 2006-05 ,pp. : 355-361

Informa Healthcare

Access to resources Recommend Favorite

Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: analysis via dual parameter flow-cytometric assay

By Kondadasula Sri   Varker Kimberly   Lesinski Gregory   Benson Don   Lehman Amy   Olencki Thomas   Monk J.   Kendra Kari   Carson William  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 8, 2008-08 ,pp. : 1137-1149

Springer Publishing Company

Access to resources Recommend Favorite

Knockdown of eIF4E suppresses cell proliferation, invasion and enhances cisplatin cytotoxicity in human ovarian cancer cells

By        

International Journal of Oncology, Vol. 47, Iss. 6, 2015-01 ,pp. : 2217-2225

Spandidos Publications

Access to resources Recommend Favorite

Endogenous accumulation of IFN- in IFN- -R -/- mice increases resistance to B16F10-Nex2 murine melanoma: a model for direct IFN- anti-tumor cytotoxicity in vitro and in vivo

By Elaine G Rodrigues   Luiz R Travassos  

Cytokines, Cellular & Molecular Therapy, Vol. 7, Iss. 3, 2002-06 ,pp. : 107-116

Informa Healthcare

Access to resources Recommend Favorite